Jianghong Cai
Sar, 999078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Histone methyltransferases SMYD2: the potential pharmacological target on cancers and aging-related diseases treatment.
Journal: European journal of medicinal chemistry
Published: September 11, 2025
A novel molecule ZYZ329 targeting histone methyltransferase SMYD3 suppresses pathological angiogenesis via the driven mitochondrial ROS/HIF-1α/VEGFA axis.
Journal: Journal of translational medicine
Published: August 28, 2025
Hydrogen Sulfide and Functional Therapy: Novel Mechanisms from Epigenetics.
Journal: Antioxidants & redox signaling
Published: November 11, 2023
Signaling pathways in rheumatoid arthritis: implications for targeted therapy.
Journal: Signal transduction and targeted therapy
Published: September 15, 2022
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway.
Journal: Signal transduction and targeted therapy
Published: January 27, 2022
Carboxyboranylamino ethanol: unprecedented discovery of boron agents for neutron capture therapy in cancer treatment.
Journal: Chemical communications (Cambridge, England)
Published: September 16, 2021
Neuron navigator 2 is a novel mediator of rheumatoid arthritis.
Journal: Cellular & molecular immunology
Published: April 28, 2021
Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
Journal: Molecules (Basel, Switzerland)
Published: September 12, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026